Quick Heal Technologies Ltd (QUICKHEAL) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Quick Heal faced challenges in FY25 due to headwinds in the consumer business and slower government buying.
- The company remains optimistic about FY26, citing a healthy pipeline and a focus on three growth levers: products, consumer segments, and geography.
- Enterprise business now contributes 40% of company revenue, and cloud product adoption has reached 31%.
- A large government deal has been closed, positively impacting the order book.
- International business is showing growth, with new partners onboarded in Europe and North America.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.